False claims about the safety of mifepristone are driving legislative and investigative action in Congress, even as major medical organizations and decades of clinical evidence support the drug’s safety. And competing interpretations of what censorship and free speech mean are impacting how health misinformation is moderated.
Abortion Pill’s Safety Called into Question in Congressional Actions Based on Misleading Data — The Monitor
